{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,26]],"date-time":"2026-08-26T20:24:41Z","timestamp":1787775881322,"version":"build-2784847793"},"reference-count":32,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"2","license":[{"start":{"date-parts":[[2025,5,1]],"date-time":"2025-05-01T00:00:00Z","timestamp":1746057600000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-sa\/4.0"}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2025,5]]},"abstract":"<jats:title>ABSTRACT<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background:<\/jats:title>\n                    <jats:p>The necessity of postmastectomy radiotherapy (PMRT) following neoadjuvant chemotherapy (NAC) in patients with ypN0 breast cancer remains a controversial clinical issue. To elucidate this issue, the present study performed a systematic review and meta-analysis, focusing on studies of clinically lymph node-negative patients exhibiting a favorable pathologic response to NAC.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Materials and Methods:<\/jats:title>\n                    <jats:p>After a comprehensive literature search of PubMed and major oncology congress abstracts, 16 studies that met the inclusion criteria were included. A fixed or random effects model was used to assess the impact of PMRT on the local recurrence rate (LRR) and survival outcomes, where appropriate.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results:<\/jats:title>\n                    <jats:p>\n                      The pooled data from ten studies indicated that PMRT significantly reduced the LRR in patients with ypN0 breast cancer (risk ratio [RR], 0.52; 95% confidence interval [CI], 0.41\u20130.67,\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      &lt; 0.00001). Moreover, a marginal increase in the overall survival (OS) rates was observed in nine studies (RR, 1.01; 95% CI, 1.00\u20131.02,\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      = 0.006), whereas no significant effect on disease-free survival (DFS) was found in six studies (RR, 1.01; 95% CI, 0.95\u20131.08,\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      = 0.72).\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions:<\/jats:title>\n                    <jats:p>Our findings suggest that PMRT is associated with reduced LRR and slightly improved OS in patients with ypN0 breast cancer. However, prospective studies are needed to provide more evidence and inform clinical decision-making.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.4103\/jcrt.jcrt_1279_24","type":"journal-article","created":{"date-parts":[[2025,5,3]],"date-time":"2025-05-03T02:04:08Z","timestamp":1746237848000},"page":"477-482","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":1,"title":["Impact of postmastectomy radiotherapy on locoregional recurrence and survival in patients with ypN0 breast cancer after neoadjuvant chemotherapy: A comprehensive meta-analysis and systematic review"],"prefix":"10.4103","volume":"21","author":[{"given":"Fangjie","family":"Ding","sequence":"first","affiliation":[{"name":"Department of Oncology, The First Affiliated Hospital of Shandong First Medical University and Shandong Provincial Qianfoshan Hospital, Shandong Lung Cancer Institute, Jinan, Shandong, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Junfeng","family":"Zhao","sequence":"additional","affiliation":[{"name":"Department of Radiation Oncology, Shandong Cancer Hospital and Institute, Shandong First Medical University, and Shandong Academy of Medical Sciences, Jinan, Shandong, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xue","family":"Wu","sequence":"additional","affiliation":[{"name":"Department of Oncology, The First Affiliated Hospital of Shandong First Medical University and Shandong Provincial Qianfoshan Hospital, Shandong Lung Cancer Institute, Jinan, Shandong, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoman","family":"Liu","sequence":"additional","affiliation":[{"name":"Department of Oncology, BinZhou Medical University Affiliated Hospital, BinZhou Medical University, Binzhou, Shandong, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yunxing","family":"Yang","sequence":"additional","affiliation":[{"name":"Department of Oncology, The First Affiliated Hospital of Shandong First Medical University and Shandong Provincial Qianfoshan Hospital, Shandong Lung Cancer Institute, Jinan, Shandong, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ying","family":"Li","sequence":"additional","affiliation":[{"name":"Department of Respiratory Oncology, Shandong Cancer Hospital and Institute, Shandong First Medical University, and Shandong Academy of Medical Sciences, Jinan, Shandong, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lili","family":"Qiao","sequence":"additional","affiliation":[{"name":"Department of Oncology, The First Affiliated Hospital of Shandong First Medical University and Shandong Provincial Qianfoshan Hospital, Shandong Lung Cancer Institute, Jinan, Shandong, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yingying","family":"Zhang","sequence":"additional","affiliation":[{"name":"Department of Oncology, The First Affiliated Hospital of Shandong First Medical University and Shandong Provincial Qianfoshan Hospital, Shandong Lung Cancer Institute, Jinan, Shandong, China"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2025,5,2]]},"reference":[{"key":"R1-20250512","doi-asserted-by":"crossref","first-page":"1477","DOI":"10.1016\/S1470-2045(22)00649-0","article-title":"Breast surgery after neoadjuvant chemotherapy:Time for a change?","volume":"23","author":"Spanheimer","year":"2022","journal-title":"Lancet Oncol"},{"key":"R2-20250512","doi-asserted-by":"crossref","first-page":"4691","DOI":"10.1200\/JCO.2004.11.129","article-title":"Postmastectomy radiation improves local-regional control and survival for selected patients with locally advanced breast cancer treated with neoadjuvant chemotherapy and mastectomy","volume":"22","author":"Huang","year":"2004","journal-title":"J Clin Oncol"},{"key":"R3-20250512","doi-asserted-by":"crossref","first-page":"2475","DOI":"10.1245\/s10434-019-07453-1","article-title":"Role of postmastectomy radiotherapy after neoadjuvant chemotherapy in breast cancer patients:A study from the Japanese breast cancer registry","volume":"26","author":"Miyashita","year":"2019","journal-title":"Ann Surg Oncol"},{"key":"R4-20250512","doi-asserted-by":"crossref","first-page":"892","DOI":"10.3389\/fonc.2020.00892","article-title":"Is there a role for post-mastectomy radiotherapy for T1-2N1 breast cancers with node-positive pathology after patients become node-negative pathology following neoadjuvant chemotherapy?","volume":"10","author":"Wang","year":"2020","journal-title":"Front Oncol"},{"key":"R5-20250512","first-page":"6632635","article-title":"Impact of postmastectomy radiotherapy on locoregional control and disease-free survival in patients with breast cancer treated with neoadjuvant chemotherapy","volume":"2021","author":"Zhang","year":"2021","journal-title":"J Oncol"},{"key":"R6-20250512","first-page":"CD014463","article-title":"Post-mastectomy radiotherapy for women with early breast cancer and one to three positive lymph nodes","volume":"6","author":"Verma","year":"2023","journal-title":"Cochrane Database Syst Rev"},{"key":"R7-20250512","doi-asserted-by":"crossref","first-page":"3892","DOI":"10.1245\/s10434-019-07635-x","article-title":"Post-mastectomy radiotherapy after neoadjuvant chemotherapy in breast cancer:A pooled retrospective analysis of three prospective randomized trials","volume":"26","author":"Krug","year":"2019","journal-title":"Ann Surg Oncol"},{"key":"R8-20250512","doi-asserted-by":"crossref","first-page":"782","DOI":"10.1016\/j.ijrobp.2010.06.027","article-title":"Local-regional recurrence with and without radiation therapy after neoadjuvant chemotherapy and mastectomy for clinically staged T3N0 breast cancer","volume":"81","author":"Nagar","year":"2011","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"R9-20250512","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1016\/j.canrad.2017.07.051","article-title":"Outcome of postmastectomy radiotherapy after primary systemic treatment in patients with clinical T1-2N1 breast cancer","volume":"22","author":"Cao","year":"2018","journal-title":"Cancer Radiother"},{"key":"R10-20250512","doi-asserted-by":"crossref","first-page":"285","DOI":"10.4048\/jbc.2019.22.e25","article-title":"The benefit of post-mastectomy radiotherapy in ypN0 patients after neoadjuvant chemotherapy according to molecular subtypes","volume":"22","author":"Cho","year":"2019","journal-title":"J Breast Cancer"},{"key":"R11-20250512","doi-asserted-by":"crossref","first-page":"e1","DOI":"10.1016\/j.ijrobp.2010.12.054","article-title":"Radiotherapy for Stage II and Stage III breast cancer patients with negative lymph nodes after preoperative chemotherapy and mastectomy","volume":"82","author":"Le Scodan","year":"2012","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"R12-20250512","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1016\/j.radonc.2021.06.032","article-title":"Postmastectomy radiation therapy following pathologic complete nodal response to neoadjuvant chemotherapy:A prelude to NSABP B-51?","volume":"162","author":"Haque","year":"2021","journal-title":"Radiother Oncol"},{"key":"R13-20250512","doi-asserted-by":"crossref","first-page":"592","DOI":"10.4143\/crt.2022.998","article-title":"Impact of postmastectomy radiation therapy on breast cancer patients according to pathologic nodal status after modern neoadjuvant chemotherapy","volume":"55","author":"Kim","year":"2023","journal-title":"Cancer Res Treat"},{"key":"R14-20250512","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1016\/j.clbc.2021.02.008","article-title":"Locoregional and distant outcomes in women with cT1-3N1 breast cancer treated with neoadjuvant chemotherapy with or without adjuvant radiotherapy","volume":"21","author":"Kozak","year":"2021","journal-title":"Clin Breast Cancer"},{"key":"R15-20250512","doi-asserted-by":"crossref","first-page":"24848","DOI":"10.18632\/oncotarget.6664","article-title":"The role of postmastectomy radiotherapy in clinically nodepositive, stage II-III breast cancer patients with pathological negative nodes after neoadjuvant chemotherapy:An analysis from the NCDB","volume":"7","author":"Liu","year":"2015","journal-title":"Oncotarget"},{"key":"R16-20250512","doi-asserted-by":"crossref","first-page":"818","DOI":"10.1093\/annonc\/mdw046","article-title":"The impact of postmastectomy and regional nodal radiation after neoadjuvant chemotherapy for clinically lymph node positive breast cancer:A National Cancer Database (NCDB) analysis","volume":"27","author":"Rusthoven","year":"2016","journal-title":"Ann Oncol"},{"key":"R17-20250512","doi-asserted-by":"crossref","first-page":"279","DOI":"10.55730\/1300-0144.5313","article-title":"Patterns of postmastectomy radiation therapy in clinically node-positive breast cancerpatients with pathologically negative lymph nodes after neoadjuvant chemotherapy","volume":"52","author":"Sayan","year":"2022","journal-title":"Turk J Med Sci"},{"key":"R18-20250512","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/j.ijrobp.2013.09.021","article-title":"The Role of postmastectomy radiation therapy after neoadjuvant chemotherapy in clinical stage II-III breast cancer patients with pN0:A multicenter, retrospective study (KROG 12-05)","volume":"88","author":"Shim","year":"2014","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"R19-20250512","doi-asserted-by":"crossref","first-page":"494","DOI":"10.1016\/j.ijrobp.2012.01.068","article-title":"Role of postmastectomy radiation after neoadjuvant chemotherapy in stage II-III breast cancer","volume":"83","author":"Fowble","year":"2012","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"R20-20250512","doi-asserted-by":"crossref","first-page":"2127","DOI":"10.1016\/S0140-6736(14)60488-8","article-title":"Effect of radiotherapy after mastectomy and axillary surgery on 10-year recurrence and 20-year breast cancer mortality:Meta-analysis of individual patient data for 8135 women in 22 randomised trials","volume":"383","author":"McGale","year":"2014","journal-title":"Lancet"},{"key":"R21-20250512","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1159\/000531117","article-title":"Conventional tools for predicting satisfactory response to neoadjuvant chemotherapy in HR+\/HER2- breast cancer patients","volume":"18","author":"Oprea","year":"2023","journal-title":"Breast Care (Basel)"},{"key":"R22-20250512","doi-asserted-by":"crossref","first-page":"1314","DOI":"10.4103\/jcrt.jcrt_2079_21","article-title":"Risk factors and prognostic factors of brain metastasis of triple-negative breast cancer:A single-center retrospective study","volume":"20","author":"He","year":"2024","journal-title":"J Cancer Res Ther"},{"key":"R23-20250512","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1016\/S1470-2045(17)30904-X","article-title":"Tumour-infiltrating lymphocytes and prognosis in different subtypes of breast cancer:A pooled analysis of 3771 patients treated with neoadjuvant therapy","volume":"19","author":"Denkert","year":"2018","journal-title":"Lancet Oncol"},{"issue":"(Suppl 2)","key":"R24-20250512","doi-asserted-by":"crossref","first-page":"S821","DOI":"10.4103\/jcrt.jcrt_1409_22","article-title":"Evaluation of treatment responses among subgroups of breast cancer patients receiving neoadjuvant chemotherapy","volume":"19","author":"Dag\u0131stanli","year":"2023","journal-title":"J Cancer Res Ther"},{"issue":"(Suppl 1)","key":"R25-20250512","doi-asserted-by":"crossref","first-page":"S335","DOI":"10.4103\/jcrt.jcrt_873_21","article-title":"Discordance of estrogen and progesterone receptors after neoadjuvant chemotherapy in locally advanced breast cancer","volume":"19","author":"Gupta","year":"2023","journal-title":"J Cancer Res Ther"},{"key":"R26-20250512","doi-asserted-by":"crossref","first-page":"1486","DOI":"10.4103\/jcrt.jcrt_56_23","article-title":"Receptor subtype and outcome of breast cancer - single-center experience from North India","volume":"20","author":"Banday","year":"2024","journal-title":"J Cancer Res Ther"},{"key":"R27-20250512","doi-asserted-by":"crossref","first-page":"479","DOI":"10.6004\/jnccn.2020.7554","article-title":"Role of immunotherapy in triple-negative breast cancer","volume":"18","author":"Keenan","year":"2020","journal-title":"J Natl Compr Canc Netw"},{"key":"R28-20250512","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/j.clbc.2021.03.007","article-title":"Advances in combining radiation and immunotherapy in breast cancer","volume":"21","author":"Nguyen","year":"2021","journal-title":"Clin Breast Cancer"},{"key":"R29-20250512","doi-asserted-by":"crossref","first-page":"109444","DOI":"10.1016\/j.intimp.2022.109444","article-title":"Combined immunotherapy for metastatic triple-negative breast cancer based on PD-1\/PD-L1 immune checkpoint blocking","volume":"113","author":"He","year":"2022","journal-title":"Int Immunopharmacol"},{"key":"R30-20250512","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1186\/s12943-024-01990-4","article-title":"Modulation of the tumor microenvironment and mechanism of immunotherapy-based drug resistance in breast cancer","volume":"23","author":"Kundu","year":"2024","journal-title":"Mol Cancer"},{"key":"R31-20250512","doi-asserted-by":"crossref","first-page":"4695","DOI":"10.1097\/JS9.0000000000001546","article-title":"CXCR6 expression correlates with radiotherapy response and immune context in triple-negative breast cancer-experimental studies","volume":"110","author":"Meng","year":"2024","journal-title":"Int J Surg"},{"issue":"(Supplement)","key":"R32-20250512","doi-asserted-by":"crossref","first-page":"S81","DOI":"10.4103\/jcrt.jcrt_2013_21","article-title":"Expression of programmed death ligand-1 (PD-L1) and tumor infiltrating lymphocytes (TILs) in breast carcinoma and their clinical significance","volume":"19","author":"Mondal","year":"2023","journal-title":"J Cancer Res Ther"}],"container-title":["Journal of Cancer Research and Therapeutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.4103\/jcrt.jcrt_1279_24","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,26]],"date-time":"2026-08-26T19:44:58Z","timestamp":1787773498000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/10.4103\/jcrt.jcrt_1279_24"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,5]]},"references-count":32,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2025]]}},"URL":"https:\/\/doi.org\/10.4103\/jcrt.jcrt_1279_24","relation":{},"ISSN":["0973-1482","1998-4138"],"issn-type":[{"value":"0973-1482","type":"print"},{"value":"1998-4138","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,5]]},"assertion":[{"value":"2024-07-04","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2025-02-18","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}